Armata Pharmaceuticals, Inc.

ARMP
$7.56 (- $0.22 - 2.83%)
Last updated: 2026-06-11 00:38 UTC
ARMP Metrics
Exchange
🇺🇸 NYSE XASE
NYSE Mkt LLCUnited StatesAmerica/New_York
SectorHealthcare
IndustryBiotechnology
ISINUS04216R1023
CUSIP04216R102
Market Price7.56
Dividend Yield N/A
Dividend Growth
1YN/A
3YN/A
5YN/A
10YN/A
Annual Dividend N/A
Latest Payout ($)N/A
Latest Payout DateN/A
Dividend FrequencyNone
P/E RatioN/A
EPS-1.66
Market Cap$228.6M
Book Value-2.64
Price to Book-2.381
Beta1.25
52w High16.34
52w Low0.9
Next Earnings DateN/A

Armata Pharmaceuticals, Inc. trades under ticker ARMP on NYSE as a stock. Use this page to review stock price, dividends, and price history. The page also shows Healthcare exposure. Identifiers: ISIN US04216R1023, CUSIP 04216R102.

About the Company
Armata Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company that focuses on the development of targeted bacteriophage therapeutics for antibiotic-resistant infections worldwide. It develops its products using its proprietary bacteriophage-based technology. The company's product candidates include AP-SA02 for the treatment of Staphylococcus aureus bacteremia; AP-PA02 for Pseudomonas aeruginosa; and AP-PA03 for the treatment of pneumonia. It has research collaboration agreement with Merck Sharp & Dohme Corp. for developing synthetic bacteriophage candidates to target undisclosed infectious disease agents. The company is based in Los Angeles, California. Armata Pharmaceuticals, Inc. operates as a subsidiary of Innoviva, Inc.
Price History